Sanofi (SNY) Equity Average (2018)

Sanofi's (SNY) quarterly Equity Average came in at $70.0 billion in Q1 2018.

Sanofi (SNY) Equity Average (2018) Analysis & Trends

Sanofi has disclosed Equity Average across 1 years of filings, most recently posting $70.0 billion for Q1 2018.

Equity Average for Q1 2018 came in at $70.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was $70.0 billion (changed N/A YoY), and the FY2025 annual result was $83.0 billion, up 1.84% from the prior year.
Equity Average came in at $70.0 billion for Q1 2018 at Sanofi.
In the past five years, Equity Average ranged from a high of $70.0 billion in Q1 2018 to a low of $70.0 billion in Q1 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	28.87 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	81.37 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	-4.96 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	49.27 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	8.92 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	23.11 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	88.29 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	19.27 Bn
10	Sanofi	63.47 Mn	-6.87 Bn	9.49 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2018	69.97 Bn